Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Public ClinicalTrials.gov record NCT00008554. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomised, Multicenter, Parallel, Open-Label Study to Compare the Efficacy, Safety, and Tolerability of GW433908 (1400 Mg Bid) and Nelfinavir (1250 Mg Bid) Over 48 Weeks in Antiretroviral Therapy Naive HIV-1 Infected Adults
Study identification
- NCT ID
- NCT00008554
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- Abacavir sulfate Drug
- Nelfinavir mesylate Drug
- Lamivudine Drug
- GW433908 Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2000
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
Started 2000
United States locations
- U.S. sites
- 23
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay Clinical Trial Ctr | Concord | California | 94520 | — |
| Ocean View Internal Medicine | Long Beach | California | 90803 | — |
| Florida ID Group | Orlando | Florida | 32801 | — |
| Hillsborough County Health Dept | Tampa | Florida | 33602 | — |
| Clinical Pharmacology Services | Tampa | Florida | 33617 | — |
| Veterans Affairs Med Ctr of North Chicago | Chicago | Illinois | 60064 | — |
| Univ of Kansas Med Ctr | Kansas City | Kansas | 661607415 | — |
| Saint Michael's Med Ctr | Newark | New Jersey | 07102 | — |
| UMDNJ - New Jersey Med School | Newark | New Jersey | 071032757 | — |
| Addiction Research and Treatment Corp | Brooklyn | New York | 11201 | — |
| Brookdale Univ Hosp and Med Ctr | Brooklyn | New York | 112123198 | — |
| Gervais Frechette | New York | New York | 10011 | — |
| Howard Grossman | New York | New York | 10011 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Univ of Rochester Med Ctr | Rochester | New York | 14642 | — |
| Bronx Municipal Hosp Ctr/Jacobi Med Ctr | The Bronx | New York | 10461 | — |
| SMO-USA Inc | Charlotte | North Carolina | 28211 | — |
| Advanced Clinical Trials Inc | Eugene | Oregon | 97401 | — |
| Thomas Jefferson Univ | Philadelphia | Pennsylvania | 19107 | — |
| Univ of Texas Med Branch | Galveston | Texas | 775550835 | — |
| MacGregor Med Association | Houston | Texas | 77054 | — |
| Walter Gaman | Irving | Texas | 75038 | — |
| Southwest Texas Methodist Hosp | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00008554, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00008554 live on ClinicalTrials.gov.